Endoscopic care in Timonium, Maryland

Francis Creighton, Jr. M.D. is a renowned institution located in Timonium, Maryland, United States. Specializing in neurotology and lateral skull base surgery, Dr. Francis Creighton offers expert medical and surgical treatment for a wide range of ear and skull base disorders. From acoustic neuromas to cochlear implantation, the institution provides cutting-edge care using minimally invasive and endoscopic approaches to ensure optimal outcomes for patients. With a focus on integrating robotic and augmented reality platforms into surgical procedures, Dr. Creighton is at the forefront of advancing surgical safety and efficiency in the field. His research has been published in prestigious medical journals, showcasing his commitment to innovation and excellence in patient care.

Johns Hopkins Minimally Invasive Surgery, located at 10755 Falls Road in Timonium, Maryland, offers advanced surgical treatments that can reduce complications and recovery time for patients. Our team of surgeons is highly trained in the latest minimally invasive techniques for conditions such as esophageal/digestive diseases, hernias, obesity, and metabolic syndrome. We are known for our ongoing research in hernia care and digestive diseases, leading to cutting-edge discoveries and advancements in clinical care. Our specialized care extends to women at risk for pain and LGBT patients who may be hesitant to seek treatment. Our internationally renowned surgeons provide individualized hernia care and approach abdominal surgical diseases in a less invasive way to improve the recovery process.

Max Kates, M.D. is a leading institution located in Timonium, Maryland, United States, specializing in urologic oncology. Dr. Max Kates, an Associate Professor of Urology and Oncology, heads the Division of Urologic Oncology at the prestigious Brady Urological Institute. With expertise in bladder and prostate cancer, Dr. Kates offers personalized treatment plans utilizing open, endoscopic, and robotic surgical approaches. He is dedicated to open communication with patients, their families, and referring providers to ensure a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic at Johns Hopkins Greenberg Bladder Cancer Institute, Dr. Kates collaborates with a team to deliver cutting-edge precision medicine approaches for bladder cancer patients. His research interests focus on novel treatments for urinary tract cancers, with over 135 journal articles to his credit. Dr. Kates is also the principal investigator on multiple trials, including the groundbreaking EA8212 BRIDGE trial comparing BCG to GemDoce chemotherapy for early stage bladder cancer.